Our results, suggesting a lack of significant change in the expression of MEG3 in GDM, are inconsistent with previous findings, which demonstrated the downregulation or upregulation of this lncRNA in the placentas of mothers with GDM [43,57]. Here, MEG3 is linked to gestational diabetes.